CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing cases of amputation due to the rising number of accidents & injuries
4.1.2. Increasing number of patients suffering from neurological disorders and nerve injury
4.1.3. Increasing incidence of hearing loss & prevalence of diabetes
4.1.4. Availability of funds and research grants with expanded target applications and new
indications
4.2. Market Restraints & Challenges
4.2.1. Lack of trained professionals
4.2.2. Availability of alternative treatment options
4.2.3. The high cost of neuroprosthetics and unfavourable reimbursement scenario
CHAPTER 5. GLOBAL NEUROPROSTHETICS MARKET – BY TECHNIQUE
5.1. Vagus Nerve Stimulation
5.2. Sacral Nerve Stimulation
5.3. Transcranial Magnetic Stimulation
5.4. Spinal Cord Stimulation
5.5. Deep Brain Stimulation
CHAPTER 6. GLOBAL NEUROPROSTHETICS MARKET – BY TYPE
6.1. Input Neural Prosthetics
6.1.1. Bionic Eye/Retinal Implants
6.1.2. Cochlear Implants
6.2. Output Neural Prosthetics
6.2.1. Cognitive Prosthetics
6.2.2. Motor Prosthetics
CHAPTER 7. GLOBAL NEUROPROSTHETICS MARKET – BY APPLICATION
7.1. Physiological Disorders
7.1.1. Urology Disorders
7.1.2. Ophthalmic Disorders
7.1.3. Cardiovascular Disorders
7.1.4. Auditory Processing Disorders
7.2. Motor Neuron Disorders
7.2.1. Epilepsy
7.2.2. Parkinson’s Disease
7.3. Cognitive Disorders
7.3.1. Paralysis
7.3.2. Alzheimer’s Disease
CHAPTER 8. GLOBAL NEUROPROSTHETICS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL NEUROPROSTHETICS MARKET - COMPANY PROFILES
9.1. NDI Medical, LLC.
9.2. Medtronic, Inc.
9.3. Cyberonics, Inc.
9.4. Cochlear Limited.
9.5. Boston Scientific Corporation
9.6. Sonova Group
9.7. ST. Jude Medical, Inc.
9.8. Retina Implant AG
9.9. NeuroPace, Inc.
9.10. Nervo Corp.
9.11. NDI Medical, Inc.
9.12. Med-El Pvt. Ltd.
CHAPTER 10. GLOBAL NEUROPROSTHETICS MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
